title: [Reading and interpreting the CPA-AIR recommendations for the diagnosis and management of juvenile systemic iupus erythematosus (continued)].
authors.forename: Hong-Mei
authors.initials: HM
authors.lastname: Song
mesh_terms: D000293:Adolescent; D001688:Biological Products / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D002681:China; D019317:Evidence-Based Medicine; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000473:pathology / Q000628:therapy*; D008181:Lupus Nephritis / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D010024:Osteoporosis / Q000209:etiology / Q000473:pathology / Q000628:therapy; D017410:Practice Guidelines as Topic / Q000592:standards*; D012720:Severity of Illness Index; D012955:Societies, Medical
chemical_list: D001688:Biological Products; D005938:Glucocorticoids; D007166:Immunosuppressive Agents